733 related articles for article (PubMed ID: 8230155)
1. Prevalence of 22q11 microdeletions in DiGeorge and velocardiofacial syndromes: implications for genetic counselling and prenatal diagnosis.
Driscoll DA; Salvin J; Sellinger B; Budarf ML; McDonald-McGinn DM; Zackai EH; Emanuel BS
J Med Genet; 1993 Oct; 30(10):813-7. PubMed ID: 8230155
[TBL] [Abstract][Full Text] [Related]
2. Microdeletions of chromosomal region 22q11 in patients with congenital conotruncal cardiac defects.
Goldmuntz E; Driscoll D; Budarf ML; Zackai EH; McDonald-McGinn DM; Biegel JA; Emanuel BS
J Med Genet; 1993 Oct; 30(10):807-12. PubMed ID: 7901419
[TBL] [Abstract][Full Text] [Related]
3. Prenatal diagnosis and molecular cytogenetic characterization of chromosome 22q11.2 deletion syndrome associated with congenital heart defects.
Kuo YL; Chen CP; Wang LK; Ko TM; Chang TY; Chern SR; Wu PS; Chen YT; Chang SY
Taiwan J Obstet Gynecol; 2014 Jun; 53(2):248-51. PubMed ID: 25017279
[TBL] [Abstract][Full Text] [Related]
4. Genetic basis of DiGeorge and velocardiofacial syndromes.
Driscoll DA
Curr Opin Pediatr; 1994 Dec; 6(6):702-6. PubMed ID: 7849818
[TBL] [Abstract][Full Text] [Related]
5. 22q11.2 distal deletion: a recurrent genomic disorder distinct from DiGeorge syndrome and velocardiofacial syndrome.
Ben-Shachar S; Ou Z; Shaw CA; Belmont JW; Patel MS; Hummel M; Amato S; Tartaglia N; Berg J; Sutton VR; Lalani SR; Chinault AC; Cheung SW; Lupski JR; Patel A
Am J Hum Genet; 2008 Jan; 82(1):214-21. PubMed ID: 18179902
[TBL] [Abstract][Full Text] [Related]
6. Confirmation that the velo-cardio-facial syndrome is associated with haplo-insufficiency of genes at chromosome 22q11.
Kelly D; Goldberg R; Wilson D; Lindsay E; Carey A; Goodship J; Burn J; Cross I; Shprintzen RJ; Scambler PJ
Am J Med Genet; 1993 Feb; 45(3):308-12. PubMed ID: 8434616
[TBL] [Abstract][Full Text] [Related]
7. CATCH 22: deletion of locus 22q11 in velocardiofacial syndrome, DiGeorge anomaly, and nonsyndromic conotruncal defects.
Hou JW; Wang JK; Tsai WY; Chou CC; Wang TR
J Formos Med Assoc; 1997 Jun; 96(6):419-23. PubMed ID: 9216164
[TBL] [Abstract][Full Text] [Related]
8. Clinical correlation of chromosome 22q11.2 fluorescent in situ hybridization analysis and velocardiofacial syndrome.
Oh AK; Workman LA; Wong GB
Cleft Palate Craniofac J; 2007 Jan; 44(1):62-6. PubMed ID: 17214538
[TBL] [Abstract][Full Text] [Related]
9. [Small deletion--large effect].
Lüerssen K; Pruggmayer M; Ptok M
HNO; 2004 Mar; 52(3):258-60. PubMed ID: 15004686
[TBL] [Abstract][Full Text] [Related]
10. Independent de novo 22q11.2 deletions in first cousins with DiGeorge/velocardiofacial syndrome.
Saitta SC; Harris SE; McDonald-McGinn DM; Emanuel BS; Tonnesen MK; Zackai EH; Seitz SC; Driscoll DA
Am J Med Genet A; 2004 Jan; 124A(3):313-7. PubMed ID: 14708107
[TBL] [Abstract][Full Text] [Related]
11. Positional mapping of loci in the DiGeorge critical region at chromosome 22q11 using a new marker (D22S183).
Mulder MP; Wilke M; Langeveld A; Wilming LG; Hagemeijer A; van Drunen E; Zwarthoff EC; Riegman PH; Deelen WH; van den Ouweland AM
Hum Genet; 1995 Aug; 96(2):133-41. PubMed ID: 7635459
[TBL] [Abstract][Full Text] [Related]
12. The Philadelphia story: the 22q11.2 deletion: report on 250 patients.
McDonald-McGinn DM; Kirschner R; Goldmuntz E; Sullivan K; Eicher P; Gerdes M; Moss E; Solot C; Wang P; Jacobs I; Handler S; Knightly C; Heher K; Wilson M; Ming JE; Grace K; Driscoll D; Pasquariello P; Randall P; Larossa D; Emanuel BS; Zackai EH
Genet Couns; 1999; 10(1):11-24. PubMed ID: 10191425
[TBL] [Abstract][Full Text] [Related]
13. Chromosome 22q11.2 microdeletions in velocardiofacial syndrome patients with widely variable manifestations.
Ravnan JB; Chen E; Golabi M; Lebo RV
Am J Med Genet; 1996 Dec; 66(3):250-6. PubMed ID: 8985481
[TBL] [Abstract][Full Text] [Related]
14. Use of fluorescence in situ hybridization (FISH) in the diagnosis of DiGeorge sequence and related diseases.
Larson RS; Butler MG
Diagn Mol Pathol; 1995 Dec; 4(4):274-8. PubMed ID: 8634784
[TBL] [Abstract][Full Text] [Related]
15. Dual-probe fluorescence in situ hybridization assay for detecting deletions associated with VCFS/DiGeorge syndrome I and DiGeorge syndrome II loci.
Berend SA; Spikes AS; Kashork CD; Wu JM; Daw SC; Scambler PJ; Shaffer LG
Am J Med Genet; 2000 Apr; 91(4):313-7. PubMed ID: 10766989
[TBL] [Abstract][Full Text] [Related]
16. 22q11 deletion in DGS/VCFS monozygotic twins with discordant phenotypes.
Vincent MC; Heitz F; Tricoire J; Bourrouillou G; Kuhlein E; Rolland M; Calvas P
Genet Couns; 1999; 10(1):43-9. PubMed ID: 10191428
[TBL] [Abstract][Full Text] [Related]
17. Submicroscopic deletions at 22q11.2: variability of the clinical picture and delineation of a commonly deleted region.
Lindsay EA; Greenberg F; Shaffer LG; Shapira SK; Scambler PJ; Baldini A
Am J Med Genet; 1995 Mar; 56(2):191-7. PubMed ID: 7625444
[TBL] [Abstract][Full Text] [Related]
18. Velo-cardio-facial syndrome associated with chromosome 22 deletions encompassing the DiGeorge locus.
Scambler PJ; Kelly D; Lindsay E; Williamson R; Goldberg R; Shprintzen R; Wilson DI; Goodship JA; Cross IE; Burn J
Lancet; 1992 May; 339(8802):1138-9. PubMed ID: 1349369
[TBL] [Abstract][Full Text] [Related]
19. Prenatal diagnosis by FISH of a 22q11 deletion in two families.
Portnoï MF; Joyé N; Gonzales M; Demczuk S; Fermont L; Gaillard G; Bercau G; Morlier G; Taillemite JL
J Med Genet; 1998 Feb; 35(2):165-8. PubMed ID: 9507401
[TBL] [Abstract][Full Text] [Related]
20. Deletions and microdeletions of 22q11.2 in velo-cardio-facial syndrome.
Driscoll DA; Spinner NB; Budarf ML; McDonald-McGinn DM; Zackai EH; Goldberg RB; Shprintzen RJ; Saal HM; Zonana J; Jones MC
Am J Med Genet; 1992 Sep; 44(2):261-8. PubMed ID: 1360769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
